Бронхіальна астма - Міністерство охорони здоров'я України

763. Delaronde S, Peruccio DL, Bauer BJ. Improving asthma treatment in a managed care population. Am JManag Care. 2005;11(6):361-8.764. Feifer RA, Verbrugge RR, Khalid M, Levin R, O’Keefe GB, Aubert RE. Improvements in asthmapharmacotherapy and self-management: An example of a population-based disease management program.Dis Manag Health Outcomes 2004;12(2):93-102.765. Homer CJ, Forbes P, Horvitz L, Peterson LE, Wypij D, Heinrich P. Impact of a quality improvementprogram on care and outcomes for children with asthma. Arch Pediatr Adolesc Med 2005;159(5):464-9.766. Kemple T, Rogers C. A mailed personalised self-management plan improves attendance and increasespatients’ understanding of asthma. Prim Care Respir J 2003;12(4):110-4.767. Berger W. Budesonide inhalation suspension for the treatment of asthma in infants and children. Drugs2005;65(14):1973-89.768. Sorkness CA, Lemanske Jr RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al. Longtermcomparison of 3 controller regimens for mild-moderate persistent childhood asthma: The PediatricAsthma Controller Trial. Journal of Allergy and Clinical Immunology 2007;119(1):64-72.769. Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. Comparative study of budesonide inhalationsuspension and montelukast in young children with mild persistent asthma. The Journal of allergy andclinical immunology 2007;120:1043-50.770. Chen Y-Z, Busse WW, Pedersen S, Tan W, Lamm C-J, O’Byrne PM. Early intervention of recent onsetmild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in earlyasthma (START) trial. Pediatric Allergy & Immunology 2006;17 Suppl(17):7-13.771. Kelly A, Tang R, Becker S, Stanley CA. Poor specificity of low growth hormone and cortisol levelsduring fasting hypoglycemia for the diagnoses of growth hormone deficiency and adrenal insufficiency.Pediatrics 2008;122(3):e522-8.772. Brémont F, Moisan V, Dutau G. Continuous subcutaneous infusion of beta 2-agonists in infantileasthma. Pediatr Pulmonol 1992;12(2):81-3.773. Payne D, Balfour-Lynn IM, Biggart EA, Bush A, Rosenthal M. Subcutaneous terbutaline in childrenwith chronic severe asthma. Pediatr Pulmonol 2002;33(5):356-61.774. Bousquet J, P. C, N. B, R. B, S. H, S. W, et al. The effect of treatment with omalizumab, an anti-IgEantibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.Allergy 2005;60(3):302-8.775. Holgate S, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, et al. Efficacy and safety of arecombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy.2004;34(4):632-8.776. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, et al. Benefits of omalizumab as addontherapy in patients with severe persistent asthma who are inadequately controlled despite best availabletherapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005;60(3):309-16.777. Robertson C, Price D, Henry R et al Short course montelukast for intermittent asthma in children: Arandomized controlled trial Am J Resp Crit Care Med 2007;175:323-9.778. Reference deleted779. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W, Kuna P. Effect of different antiasthmatictreatments on exercise-induced bronchoconstriction in children with asthma. Journal of Allergy &ClinicalImmunology 2008;121(2):383-9.780. Sturdy PM, Butland BK, Anderson HR, Ayres JG, Bland JM, Harrison BD, et al. Deaths certified asasthma and use of medical services: a national case-control study. Thorax 2005;60(11):909-15.781. Harrison B, Slack R, Berrill WT, Burr ML, Stableforth DE, Wright SC. Results of a nationalconfidential enquiry into asthma deaths. Asthma J 2000;5:180-6.782. Arnold DH, Gebretsadik T, Minton PA, Higgins S, Hartert TV. Clinical measures associated withFEV1 in persons with asthma requiring hospital admission. American Journal of Emergency Medicine2007;25(4):425-9.783. British Thoracic Society. Guideline for emergency oxygen use in adult patients. Thorax 2008;63(suppl.6):68.784. Carruthers D, Harrison BD. Arterial blood gas analysis or oxygen saturation in the assessment of acuteasthma? Thorax 1995;50:186-8.262